ACRS vs AWK · rev $18.7M vs P/E 22, rev $4.65B
Aclaris Therapeutics Inc (ACRS) versus American Water Works (AWK) — a side-by-side from cached financials, not a winner call.
Aclaris Therapeutics Inc (ACRS) is a biotechnology company listed on NASDAQ.
American Water Works (AWK) is a utilities - regulated water company listed on US.
Latest reported ACRS revenue for 2024-12-31 was $18.7M. Net income was -$132.1M. Revenue was down 40.1% from 2023-12-31 to 2024-12-31. ACRS currently screens at market cap $615.9M.
Latest reported AWK revenue for 2024-12-31 was $4.65B. Net income was $239.0M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
ACRS currently screens at market cap $615.9M. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
Not investment advice. Open the ACRS and AWK stock pages for the full models.
Not investment advice.